哮喘、皮质类固醇与稳态负荷生物标志物的关联:一项横断面研究
该研究基于英国Understanding Society调查1-3波(2009-2012年)9816名社区成人数据,构建包含12种生物标志物的性别特异性稳态负荷指数,在控制社会经济地位后分析哮喘状态与皮质类固醇处方与稳态负荷的关联。结果显示,当前治疗但未使用皮质类固醇的哮喘患者稳态负荷为无哮喘者的1.21倍(p<0.001),使用吸入性皮质类固醇的哮喘患者约为无哮喘者的1.12倍(p<0.001),该关联在敏感性分析中持续存在,且似由脱氢表雄酮硫酸盐、腰高比和C反应蛋白等特定生物标志物驱动。结论指出,即使是最轻度未使用吸入性皮质类固醇的哮喘组也存在早期衰老表现,稳态负荷有助于理解哮喘中观察到的全因死亡率和多病共存增加。
要点
- 当前治疗但未用皮质类固醇的哮喘患者稳态负荷为无哮喘者的1.21倍(p<0.001)。
- 使用吸入性皮质类固醇的哮喘患者稳态负荷约为无哮喘者的1.12倍(p<0.001)。
- 关联似由脱氢表雄酮硫酸盐、腰高比和C反应蛋白等生物标志物驱动。
核心结论
- 即使是最轻度未使用吸入性皮质类固醇的哮喘组也存在以稳态负荷升高为表现的早期衰老。
- 稳态负荷有助于理解哮喘中观察到的全因死亡率和多病共存增加。
研究设计与样本
- 数据来自Understanding Society调查1-3波(2009-2012年),为英国社区成人全国代表性调查。
- 基于12种生物标志物构建性别特异性稳态负荷指数,样本量为9816名成人。
- 采用回归分析 examine 哮喘状态和皮质类固醇处方与稳态负荷及其组成生物标志物的关联,控制社会经济地位(n=9805)。
主要发现
- 当前治疗但未处方皮质类固醇的哮喘患者稳态负荷为无哮喘者的1.21倍(p<0.001)。
- 接受吸入性皮质类固醇的哮喘患者稳态负荷约为无哮喘者的1.12倍(p<0.001)。
- 该关联在敏感性分析中持续存在,且似由脱氢表雄酮硫酸盐、腰高比和C反应蛋白等特定生物标志物驱动。
临床怎么用
- 临床评估哮喘患者时应关注稳态负荷相关生物标志物(如脱氢表雄酮硫酸盐、腰高比、C反应蛋白)。
- 即使轻度哮喘且未使用吸入性皮质类固醇的患者也可能存在早期衰老,需综合管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Allostatic load, a measure of early ageing or 'wear and tear' from adapting to environmental challenges, has been suggested as a framework with which to understand the stress-related disruption of multiple biological systems which may be linked to asthma. Considering the socioeconomic context is also critical given asthma and allostatic overload are more common in lower socioeconomic groups. AIMS: Estimate the relationship between allostatic load and its constituent biomarkers, asthma and corticosteroid prescribing while controlling for socioeconomic status. METHODS: Data from Understanding Society (a nationally representative survey of UK community-dwelling adults) waves 1-3 (2009-2012) allowed the identification of a sex-specific risk profile across 12 biomarkers used to construct an Allostatic Load Index for a sample of 9816 adults. Regression analyses were used to examine the association of asthma status and corticosteroid prescriptions with allostatic load and its constituent biomarkers while controlling for socioeconomic status (n=9805). RESULTS: Subjects with currently treated asthma and no corticosteroid prescription have an allostatic load 1.21 times higher than those without asthma (p<0.001). Asthmatic subjects in receipt of inhaled corticosteroids had an allostatic load, approximately 1.12 times higher than those without asthma (p<0.001). This association persisted in sensitivity analyses and appeared to be driven by an association with specific biomarkers (dehydroepiandrosterone-sulfate, waist-to-height ratio and C-reactive protein). CONCLUSION: Early ageing, in the form of a higher allostatic load, was present even in the mildest asthma group not receiving inhaled corticosteroids. Allostatic load is helpful in understanding the increased all-cause mortality and multimorbidity observed in asthma.
引用
- Barry LE, O'Neill C, Heaney LG, et al. Association between asthma, corticosteroids and allostatic load biomarkers: a cross-sectional study. Thorax. 2020. PMID: 32796118. doi:10.1136/thoraxjnl-2019-214139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。